- Previous Close
54.86 - Open
54.34 - Bid 55.36 x 100000
- Ask 55.66 x 100000
- Day's Range
54.34 - 54.34 - 52 Week Range
50.20 - 65.02 - Volume
900 - Avg. Volume
314 - Market Cap (intraday)
25.596B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
81.10 - EPS (TTM)
0.67 - Earnings Date Feb 26, 2025
- Forward Dividend & Yield 0.83 (1.52%)
- Ex-Dividend Date Apr 4, 2025
- 1y Target Est
--
Novonesis A/S produces and sells produces various industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, and sewage, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
www.novonesis.com10,582
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NZM2.F
View MorePerformance Overview: NZM2.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NZM2.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NZM2.F
View MoreValuation Measures
Market Cap
25.84B
Enterprise Value
27.35B
Trailing P/E
81.88
Forward P/E
27.17
PEG Ratio (5yr expected)
0.23
Price/Sales (ttm)
6.53
Price/Book (mrq)
2.29
Enterprise Value/Revenue
7.14
Enterprise Value/EBITDA
41.51
Financial Highlights
Profitability and Income Statement
Profit Margin
7.98%
Return on Assets (ttm)
5.54%
Return on Equity (ttm)
4.67%
Revenue (ttm)
3.83B
Net Income Avi to Common (ttm)
305.8M
Diluted EPS (ttm)
0.67
Balance Sheet and Cash Flow
Total Cash (mrq)
280M
Total Debt/Equity (mrq)
16.08%
Levered Free Cash Flow (ttm)
157.66M